Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Theratechnologies Inc T.TH

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  THERF

Theratechnologies Inc is a pharmaceutical company addressing unmet medical needs in metabolic disorders. EGRIFTA is its registered trademark in the USA and it is used to commercialize its first product using its internally developed compound, tesamorelin.
Price: $1.40 Volume: 127,276
Change: $-0.01 % Change: -0.71%
Day High/Low: 1.43/1.39 52 Week High/Low: 1.49/0.325
Last Traded: May 27, 2015 11:54 Transaction Volume: 100
Open: 1.42 Previous Close: 1.41
Bid: 1.39 Ask: 1.40
Bid Size: 16500 Ask Size: 4200
Market Cap: 85.4m Shares Out: 61.0m
PE Ratio: N/A Dividend Yield: N/A

Opinion

Euro Pacific raises Theratechnologies (T.TH) target to $1

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   October 20, 2014
0 stars

Mystery Movers: Biomed shares surging, triple digit rises all over, executives baffled

When you're standing on a launchpad and a rocket is taking off, the best place to be is on the rocket.

Chris Parry   November 19, 2013
0 stars

Mystery Movers: Spectral Diagnostics jumps 22% as Canadian biotech goes viral

You're still looking for rocks in the ground? Get with the program: Biotech is booming.

Chris Parry   November 5, 2013
0 stars

Junior energy stock pops on shale oil license award

This as a small pharmaceutical stock dropped following a non-compliance notice Friday

Sean Mason   June 22, 2012
0 stars

Latest Bullboard Posts

  • RE:RE:RE:RE:RE:RE:RE:RE:Sales

    0 stars

    Increasing the SP needs to be a high ranking priority and Luc can surely multi task ....The faster the SP rises the more options the...

    2.5 stars


  • RE:RE:RE:RE:RE:RE:RE:Sales

    5 stars

    Perosnally, I would rather have management spend most of their time making sure they deliver good results as the markets will take care...

    2.5 stars


  • RE:RE:RE:RE:RE:RE:Sales

    0 stars

    Managing the stock price is also part of the CEO s responsibilities.If in fact there is a FOR SALE sign on the remaining 3 million shares...

    2.5 stars


  • RE:RE:RE:RE:RE:Sales

    3 stars

    "Meanwhile, you may have noticed Armistice Capital reduced its stake in the company to 5.1% as of the end of April. Hedge funds have a...

    3 stars


  • RE:RE:RE:RE:RE:hang tight

    0 stars

    I agree.  Everyone has their own fundamentals.  I am sure the UBS client is happy.  At this price it is almost 5 times.  How often can...

    3 stars